Title: Immunoproteomic Profiling of Antiviral Antibodies in New-Onset Type 1 Diabetes Using Protein Arrays
Special MTA: None
ATGCCGGATGTTTTATAGGGTCCAGTCCTCCTCAGATCTCAAACAATGATGGAAACACCC
GCGGAGAGCGTCAGGGCCCGGGTCAGCTCGGTTACCTTTTATAATGTCACCCAGACCGCA
GGGCGGTGGTGGGCGATTTGGGTCGTGGGCATCGTGCCCATCAAAAGGGAGGACGTTGAG
ACTCTGATCGTGGTGCAGGCCTGCCAGCCGCCGCTTGGAGGCTCCCTGGAGCCCCCCGTG
GTCAACGCGCCCTCGACTACCGAACTCAACTTTTTGCGATGGGAGCGGGAGCTCAGGCGC
AGCGGGGGGCTCATTGCTATGCTCGCCGATGCCGCCGAGAAGGACCTATTTGACCTTTCA
TTTAGAACCCGAGACCGCAGACTCTTGTCCGCCGCCCGGGTGGAGGATGAGCAGGGCCTC
ATCTTCCAGCCTCTCTTTCCAGCACAGGTGGTCTGCCAAAGCTGCTCGGGGGATGATGGG
CGGGACCAACAACCCCCACCTGGTGATGGCTTCGGGTCCGAGGTGGAGGGGGAACAGACA
TGCCCCCATGCTCAGAGGCACTCTGAGTCTCCCGGACAGTTGGACGTATACATCAGGACA
CCGCGTGGGGATGTTTTCACCTATTCCACCGAGACTCCCGACGACCCCTCTCCCGTCCCC
TTTAGGGACATCCTGCGACCGGTCACTTATGAAGTAGATCTGGTGTCGTCCGACGGGGCC
ACCGGCCGTGGTGGGGACGCCCGACGGCACCGCGTCAGCCTGAAAATTCTCGAGCCGGCT
GGGGGATTCGAGTCCTGGCTTGTCAACTCTTGGAGTATGGCCGGGGGCGGGCTCTACGCC
TTCCTCCGCAGTATCTATGCCTCCTGCTACGCCAACCACAGAGGCACCAAGCCCATCTTC
TACCTCCTGGACCCCGAACTCTGCCCAGGGGGCTCAGATTTCCAGCCCTATGTCCCGGGC
TTTCCCTTCCTGCCCATCCATTATGTGGGACGGGCGAGGCCGGCCTTCTGGCACCGGGCG
CCACACAGCGAGGGTCTCCTGCTACTGGACCTGAACCTGGGAGTCTCTGGGACGCCCCTG
GCAGACGCCCTCCTGGGCCTCGACGCGCGGTCAGGGCAACGACGCGGCTCGCTGCTCCTA
CAACAAATCTGGCCCCCGACCCGAAAGGAGATTAACCCTCGCCACGTTTGCACGCGGGAG
GGCGGCGAGGGAGGGGGGGAGGACGAGACGACGGTGGTTGGGCGCGCGGAGGCCACAGCC
ATCCTTGAGGCTGATGCCACTTGGTGGCTCTACGAATTGGCCCGCTGCCACCTCTCTGCC
AGGGGCGCCCCTGTGGGAACGCCTGATGGCGGAGGGCAGGCGCGGGACGCGCAAACCTGG
CTGCGGGCCCTTCACCGCTATGGCACCTCAGACACGCGACGGGCACTCGGGGGCCTCTAC
ACCGCCGTCACCCGGGTTCTCCTCCACGCGGCCGCTGACCTAGGACTGACCTGGGCTTAT
GCAGACGAGTTCATCCTGGGCTTTGTGGCAACAACCTCCGCCCATCCTTCAGAGGAGCCA
CTAGCACAGGCTTTCCTGCAAGGTGTGAAAGACTCGGAGGATGCCAGCCGGCTCGACCGG
GATGTTATGGGCGGAGAGGCCACCGTGGCCCGCAGACACATTCGGGTGAAGGCTCGACGC
GGGCCCGCGTGCCTACTGATGGCCATCTTTCAGGGGGATCTTTACGTGGGTGGATGTAGG
GAGCACTCGGGGCCCTTTTTGGTCTGGCACGAAGCCTTCTCCTGGACCCTGGACCAACTA
GCGGCGAGACCCGAGGCAGACAAGGCCCCGCCATCCCACGACCACCTGTTGACCCTGGTC
CGCGACCTGACCCGGAGACTGGCCCCTGGGCGGCGCCGAAACAGGTTTTGGGCTCTTCCG
CGAGCCTGGCTTCAGCGGCTGCGGAGGGCTGGGCTGCGCCTCTCTGGAAGCCACGTGTGT
CTCCTGGACAAGGATGGAGCGCGCCCGGCCCCCTGCCAGACGGCCACTGAGCATGGTCTC
AGCCCCACCGCCTACTTTCGAGAGATTATGGCCTTTCTGCTTGATGTGATATCGGCCCTC
CACCCCGGCTACGCCATGCCTATGGAAATCACTCGAGAGACAGATTTACTGATGACTGTT
CTCAGTTTATTCTAG
MPDVL*GPVLLRSQTMMETPAESVRARVSSVTFYNVTQTAGRWWAIWVVGIVPIKREDVE TLIVVQACQPPLGGSLEPPVVNAPSTTELNFLRWERELRRSGGLIAMLADAAEKDLFDLS FRTRDRRLLSAARVEDEQGLIFQPLFPAQVVCQSCSGDDGRDQQPPPGDGFGSEVEGEQT CPHAQRHSESPGQLDVYIRTPRGDVFTYSTETPDDPSPVPFRDILRPVTYEVDLVSSDGA TGRGGDARRHRVSLKILEPAGGFESWLVNSWSMAGGGLYAFLRSIYASCYANHRGTKPIF YLLDPELCPGGSDFQPYVPGFPFLPIHYVGRARPAFWHRAPHSEGLLLLDLNLGVSGTPL ADALLGLDARSGQRRGSLLLQQIWPPTRKEINPRHVCTREGGEGGGEDETTVVGRAEATA ILEADATWWLYELARCHLSARGAPVGTPDGGGQARDAQTWLRALHRYGTSDTRRALGGLY TAVTRVLLHAAADLGLTWAYADEFILGFVATTSAHPSEEPLAQAFLQGVKDSEDASRLDR DVMGGEATVARRHIRVKARRGPACLLMAIFQGDLYVGGCREHSGPFLVWHEAFSWTLDQL AARPEADKAPPSHDHLLTLVRDLTRRLAPGRRRNRFWALPRAWLQRLRRAGLRLSGSHVC LLDKDGARPAPCQTATEHGLSPTAYFREIMAFLLDVISALHPGYAMPMEITRETDLLMTV LSLF*
Coding Sequence Details
Recommended Growth Condition: